Last updated on October 2014

A multicenter, randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients


Brief description of study

A multicenter, randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients

Detailed Study Description

The purpose of the study to evaluate the efficacy, safety and tolerability of intravenous infusion of serelaxin, when added to standard therapy, in acute heart failure (AHF) patients.

Clinical Study Identifier: TX139427

Contact Investigators or Research Sites near you

Start Over

Courtney Lee

University of South Florida - Tampa General Hospital
Tampa, FL USA
  Connect »